Notice of Meeting, 65892 [2012-26597]
Download as PDF
<![CDATA[
65892
Federal Register / Vol. 77, No. 211 / Wednesday, October 31, 2012 / Notices
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Dated: October 12, 2012.
Carolyn M. Clancy,
Director.
[FR Doc. 2012–26596 Filed 10–30–12; 8:45 am]
BILLING CODE M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Notice of Meeting
Agency for Healthcare Research
and Quality, HHS.
ACTION: Notice.
AGENCY:
In accordance with section 10
(a)(2) of the Federal Advisory
Committee Act (5 U.S.C. App. 2),
announcement is made of an Agency for
Healthcare Research and Quality
(AHRQ) Special Emphasis Panel (SEP)
meeting on ‘‘AHRQ NATIONAL
RESEARCH SERVICE AWARDS (NRSA)
INSTITUTIONAL RESEARCH
TRAINING GRANTS (T32)’’.
DATES: November 14–15, 2012 (Open on
November 14 from 8:00 a.m. to 8:30 a.m.
and closed for the remainder of the
meeting).
SUMMARY:
Gaithersburg Marriott, RIO,
9751 Washingtonian Boulevard,
Gaithersburg, MD 20878.
FOR FURTHER INFORMATION CONTACT:
Anyone wishing to obtain a roster of
members, agenda or minutes of the nonconfidential portions of this meeting
should contact: Mrs. Bonnie Campbell,
Committee Management Officer, Office
of Extramural Research, Education and
Priority Populations, AHRQ, 540
Gaither Road, Room 2038, Rockville,
Maryland 20850, Telephone: (301) 427–
1554.
Agenda items for this meeting are
subject to change as priorities dictate.
SUPPLEMENTARY INFORMATION: A Special
Emphasis Panel is a group of experts in
fields related to health care research
who are invited by the Agency for
Healthcare Research and Quality
(AHRQ), and agree to be available, to
conduct on an as needed basis,
scientific reviews of applications for
AHRQ support.
Individual members of the Panel do
not attend regularly-scheduled meetings
and do not serve for fixed terms or a
tkelley on DSK3SPTVN1PROD with NOTICES
ADDRESSES:
VerDate Mar<15>2010
17:08 Oct 30, 2012
Jkt 229001
long period of time. Rather, they are
asked to participate in particular review
meetings which require their type of
expertise.
Substantial segments of the SEP
meeting referenced above will be closed
to the public in accordance with the
provisions set forth in 5 U.S.C. App. 2,
section 10(d), 5 U.S.C. 552b(c)(4), and 5
U.S.C. 552b(c)(6). Grant applications for
‘‘AHRQ NATIONAL RESEARCH
SERVICE AWARDS (NRSA)
INSTITUTIONAL RESEARCH
TRAINING GRANTS (T32)’’ are to be
reviewed and discussed at this meeting.
The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Dated: October 12, 2012.
Carolyn M. Clancy,
Director.
[FR Doc. 2012–26597 Filed 10–30–12; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Patient Safety Organizations:
Voluntary Relinquishment From PDR
Secure, LLC
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of Delisting.
AGENCY:
The Patient Safety and
Quality Improvement Act of 2005
(Patient Safety Act), Public Law 109–41,
42 U.S.C. 299b–21–b–26, provides for
the formation of Patient Safety
Organizations (PSOs), which collect,
aggregate, and analyze confidential
information regarding the quality and
safety of health care delivery. The
Patient Safety and Quality Improvement
Final Rule (Patient Safety Rule), 42 CFR
Part 3, authorizes AHRQ, on behalf of
the Secretary of HHS, to list as a PSO
an entity that attests that it meets the
statutory and regulatory requirements
for listing. A PSO can be ‘‘delisted’’ by
the Secretary if it is found no longer to
meet the requirements of the Patient
Safety Act and Patient Safety Rule, or
when a PSO chooses to voluntarily
relinquish its status as a PSO for any
reason. AHRQ has accepted a
notification of voluntary relinquishment
from PDR Secure, LLC of its status as a
SUMMARY:
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
PSO, and has delisted the PSO
accordingly.
DATES: The directories for both listed
and delisted PSOs are ongoing and
reviewed weekly by AHRQ. The
delisting was effective at 12:00 Midnight
ET (2400) on August 31, 2012.
ADDRESSES: Both directories can be
accessed electronically at the following
HHS Web site: https://
www.pso.AHRQ.gov/.
FOR FURTHER INFORMATION CONTACT:
Eileen Hogan, Center for Quality
Improvement and Patient Safety, AHRQ,
540 Gaither Road, Rockville, MD 20850;
Telephone (toll free): (866) 403–3697;
Telephone (local): (301) 427–1111; TTY
(toll free): (866) 438–7231; TTY (local):
(301) 427–1130; Email:
pso@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
Background
The Patient Safety Act authorizes the
listing of PSOs, which are entities or
component organizations whose
mission and primary activity is to
conduct activities to improve patient
safety and the quality of health care
delivery.
HHS issued the Patient Safety Rule to
implement the Patient Safety Act.
AHRQ administers the provisions of the
Patient Safety Act and Patient Safety
Rule (PDF file, 450 KB. PDF Help)
relating to the listing and operation of
PSOs. The Patient Safety Rule
authorizes AHRQ to list as a PSO an
entity that attests that it meets the
statutory and regulatory requirements
for listing. A PSO can be ‘‘delisted’’ if
it is found no longer to meet the
requirements of the Patient Safety Act
and Patient Safety Rule, or when a PSO
chooses to voluntarily relinquish its
status as a PSO for any reason. Section
3.108(d) of the Patient Safety Rule
requires AHRQ to provide public notice
when it removes an organization from
the list of federally approved PSOs.
AHRQ has accepted a notification
from PDR Secure, LLC, PSO number
P0098, which is a component entity of
PDR Network, LLC, to voluntarily
relinquish its status as a PSO.
Accordingly, PDR Secure, LLC was
delisted effective at 12:00 Midnight ET
(2400) on August 31, 2012. PDR
Network, LLC represents that it has
patient safety work product (PSWP) in
its possession. The PSO is obligated to
meet the requirements of section
3.108(c)(2)(i) of the Patient Safety Rule
to notify the sources from which it
received PSWP of the PSO’s intention to
cease PSO operations and activities, to
relinquish voluntarily its status as a
PSO, to request that these other entities
E:\FR\FM\31OCN1.SGM
31OCN1
]]>Agencies
[Federal Register Volume 77, Number 211 (Wednesday, October 31, 2012)]
[Notices]
[Page 65892]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-26597]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Notice of Meeting
AGENCY: Agency for Healthcare Research and Quality, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with section 10 (a)(2) of the Federal Advisory
Committee Act (5 U.S.C. App. 2), announcement is made of an Agency for
Healthcare Research and Quality (AHRQ) Special Emphasis Panel (SEP)
meeting on ``AHRQ NATIONAL RESEARCH SERVICE AWARDS (NRSA) INSTITUTIONAL
RESEARCH TRAINING GRANTS (T32)''.
DATES: November 14-15, 2012 (Open on November 14 from 8:00 a.m. to 8:30
a.m. and closed for the remainder of the meeting).
ADDRESSES: Gaithersburg Marriott, RIO, 9751 Washingtonian Boulevard,
Gaithersburg, MD 20878.
FOR FURTHER INFORMATION CONTACT: Anyone wishing to obtain a roster of
members, agenda or minutes of the non-confidential portions of this
meeting should contact: Mrs. Bonnie Campbell, Committee Management
Officer, Office of Extramural Research, Education and Priority
Populations, AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland
20850, Telephone: (301) 427-1554.
Agenda items for this meeting are subject to change as priorities
dictate.
SUPPLEMENTARY INFORMATION: A Special Emphasis Panel is a group of
experts in fields related to health care research who are invited by
the Agency for Healthcare Research and Quality (AHRQ), and agree to be
available, to conduct on an as needed basis, scientific reviews of
applications for AHRQ support.
Individual members of the Panel do not attend regularly-scheduled
meetings and do not serve for fixed terms or a long period of time.
Rather, they are asked to participate in particular review meetings
which require their type of expertise.
Substantial segments of the SEP meeting referenced above will be
closed to the public in accordance with the provisions set forth in 5
U.S.C. App. 2, section 10(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C.
552b(c)(6). Grant applications for ``AHRQ NATIONAL RESEARCH SERVICE
AWARDS (NRSA) INSTITUTIONAL RESEARCH TRAINING GRANTS (T32)'' are to be
reviewed and discussed at this meeting. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Dated: October 12, 2012.
Carolyn M. Clancy,
Director.
[FR Doc. 2012-26597 Filed 10-30-12; 8:45 am]
BILLING CODE 4160-90-M
